Pfizer and BioNTech could secure emergency US and European authorisation for their Covid-19 vaccine next month, the drugmaker has said. Final trial results showed that the vaccine had a 95% success rate and no serious side effects. The US Food and Drug Administration could grant emergency-use by the middle of December, BioNTech chief executive Ugur Sahin told Reuters TV. Conditional approval in the European Union could be secured in the second half of December, he added. If all goes well, the drugmaker is likely to start delivering vaccine before Christmas.
Maharashtra announces stricter Covid curbs from April 22
Delhi: IAF roped in to bring in oxygen cylinders, medicines for DRDO's Covid hospital
Covid-19: Mamata Banrjee rules out lockdown in West Bengal
Covid-19: Night curfew and other curbs in Goa; board exams postponed
India's Covid-19 second wave peak may be reached in mid-May: CEA Subramanian
Sisodia takes Vij head-on, says people from other states also being treated in Delhi
Bengaluru to get 2000 more beds, says Karnataka Health Minister
Covid vaccine pricing discriminatory: Rahul invokes DeMo to slam govt
Covid-19 crisis: only 5 hours of oxygen left at Ganga Ram hospital
These many Indians have tested Covid+ after taking second vaccine shot
Modi-made disaster: Mamata slams PM over resurgence in Covid-19 cases
India has twice the number of active Covid cases than last year: Centre
Mumbai doctor dies of Covid after saying goodbye on Facebook
Covid-19: around 77,000 migrant workers returned home from Ghaziabad
Delhi Police help arrange, transport oxygen cylinders for critical Covid-19 patients
Covaxin neutralises Covid double mutant strain: ICMR
At least 24 Covid-19 patients dead at Nashik hospital due to interrupted oxygen supply
Fight over Oxygen: Haryana accuses Delhi of 'looting' tanker
Oxygen cylinders looted in MP's Damoh hospital as demand rises amid alarming Covid surge
Indrani Mukerjea, 37 jail inmates test Covid +ve at Byculla jail